Legal status · Canada
Is Myostatin legal in Canada?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. Myostatin is not an approved medicine in Canada; its classification is "Not authorized; research use". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 4 human studies are cited on its profile.
Myostatin in Canada at a glance
| Classification | Not authorized; research use |
|---|---|
| Health Canada approval status | Not approved by Health Canada |
| Human studies cited | 4 of 6 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Myostatin profile, checked against Health Canada, Health Products and Food Branch (Health Canada) listings at the reviewed date.
What this means
- 01
No product containing Myostatin is approved by Health Canada for any use in Canada, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in Canada. This page is general information, not legal advice.
What Myostatin is
The brake on muscle growth. Knock it out in a mouse and you get a mouse twice as muscular, which launched a field. In primates the dominant brake turns out to be a different protein.
Myostatin is made by skeletal muscle and acts back on skeletal muscle to restrain its growth. It is a chalone, a signal whose job is to stop a tissue getting bigger.
Mechanism: Circulates as a latent disulfide-linked dimer held inactive by its own propeptide. Once activated it signals through activin type II receptors, principally ActRIIB, with type I receptors ALK4 and ALK5, through SMAD2 and SMAD3, to suppress muscle protein synthesis and satellite cell activity.
Regulatory history: Myostatin is an endogenous protein, not a drug. Drugs targeting the pathway are investigational; apitegromab has phase 3 data in spinal muscular atrophy.
How Health Canada treats this kind of product
Authorises drugs for sale through a Notice of Compliance and Drug Identification Number. A compound that is not authorised for sale cannot lawfully be sold for human use, and personal importation of prescription drugs is limited.
The classification above is the The Longevity Archive reading of Health Canada, Health Products and Food Branch listings for Myostatin at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Myostatin in other countries
United States
Not approvedNot a drug; endogenous hormone and research infusion peptide
Is Myostatin legal in the United States?United Kingdom
Not approvedNot a licensed medicine; research use
Is Myostatin legal in the United Kingdom?Australia
Not approvedNot approved; research use
Is Myostatin legal in Australia?Frequently asked questions
Is Myostatin legal in Canada?
No. Myostatin is not an approved medicine in Canada; its classification is "Not authorized; research use". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 4 human studies are cited on its profile.
Can I buy Myostatin in Canada?
No approved product exists to buy. In Canada Myostatin is classified as "Not authorized; research use", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.
Is Myostatin Health Canada approved?
No. In Canada Myostatin is classified as "Not authorized; research use", which is not a Health Canada marketing approval. For comparison, the US FDA status is: Myostatin is an endogenous protein, not a drug. Drugs targeting the pathway are investigational; apitegromab has phase 3 data in spinal muscular atrophy.. On the evidence, 4 human studies are cited on its profile.
Related compounds in Canada
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Myostatin live on its compound profile.
Myostatin profileThis page is general information about the regulatory status of Myostatin in Canada, current as of Sep 2026. It is not legal advice, and classifications change; check Health Canada, Health Products and Food Branch directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.